CompletedNot Applicable

Glutamine With Topical Corticosteroids for Lichen Planus Treatment

Egypt30 participantsStarted 2019-04-01

Plain-language summary

Lichen planus (LP) is an inflammatory skin disease of unknown etiology. Glutamine promotes protein and collagen synthesis, imparts immunity, and maintains the alimentary canal mucosa structure.

Who can participate

Age range30 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients clinically and histopathologically diagnosed to be suffering from EOLP.
✓. Patients who had symptoms i.e. pain and/or burning sensation secondary to EOLP.
✓. Patients under stressful life conditions as evidenced by ISMA-UK Stress Questionnaire
✓. Males and Females with an age ranging from 30-60years

Exclusion criteria

✕. Patients suspected to have a lichenoid drug reaction or lichenoid contact allergy.
✕. Patients suffering from any systemic diseases (such as diabetes, cardiovascular, liver disorder, renal dysfunction)
✕. Patients with findings of any physical or mental abnormality which would interfere with or be affected by the study procedure.

What they're measuring

Change in oral lichen planus lesions severity

Timeframe: at baseline, 1 months and 3 months

Trial details

NCT IDNCT04442633

SponsorHams Hamed Abdelrahman

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-08-01

View on ClinicalTrials.gov More Lichen Penis Planus trials